Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-2206 in Relapsed or Refractory Diffuse Large B Cell Lymphoma
NCT01466868Phase 2Terminated
- Sponsor
- Centre Léon Bérard
- Start
- Nov 2011
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MK-2206 in diffuse large B-cell lymphoma (DLBCL), sponsored by Centre Léon Bérard. Started Nov 2011; status: terminated.
02
Drugs
MK-2206
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01466868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01466868.